The effects of atenolol (tenormin) and methyldopa on simple tests of central nervous function
- PMID: 9954
- PMCID: PMC1402646
- DOI: 10.1111/j.1365-2125.1975.tb00571.x
The effects of atenolol (tenormin) and methyldopa on simple tests of central nervous function
Abstract
Two identical studies, one comparing the effect of single doses of a new beta-adrenoceptor blocker, atenolol (Tenormin) (50 mg and 100 mg) and placebo, and the other comparing the effect of single doses of methyldopa (250 mg and 500 mg) and placebo, in healthy volunteers, were carried out. 2 In both studies the effect of the drugs upon reaction time, critical flicker frequency, subjective drowsiness, pulse rate and blood pressure was measured. 3 Atenolol produced no effect upon reaction time, critical flicker frequency or subjective feelings, while methyldopa produced a statistically significant prolongation of reaction time and a statistically significant increase in the subjective sensation of drowsiness. 4 Atenolol produced statistically significant reductions in systolic and diastolic blood pressure and in pulse rate while methyldopa was without effect. 5 It is concluded that atenolol is unlikely to produce the side effects of sedation or drowsiness.
Similar articles
-
Effects of atenolol and propranolol on human performance and subjective feelings.Psychopharmacology (Berl). 1979 Jan 31;60(2):211-5. doi: 10.1007/BF00432296. Psychopharmacology (Berl). 1979. PMID: 106432 Clinical Trial.
-
Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.Br J Clin Pharmacol. 1988 Aug;26(2):121-8. doi: 10.1111/j.1365-2125.1988.tb03378.x. Br J Clin Pharmacol. 1988. PMID: 2905148 Free PMC article. Clinical Trial.
-
Central effects of repeated administration of atenolol and captopril in healthy volunteers.Eur J Clin Pharmacol. 1994;46(1):23-8. doi: 10.1007/BF00195911. Eur J Clin Pharmacol. 1994. PMID: 8005182 Clinical Trial.
-
Comparison of antihypertensive activity of atenolol and methyldopa at rest and during exercise.Int J Clin Pharmacol Ther Toxicol. 1981 Oct;19(10):440-4. Int J Clin Pharmacol Ther Toxicol. 1981. PMID: 7287240
-
Central effects of beta-adrenoceptor antagonists.Clin Pharmacol Ther. 1983 Jan;33(1):52-7. doi: 10.1038/clpt.1983.7. Clin Pharmacol Ther. 1983. PMID: 6848299 Clinical Trial.
Cited by
-
The effects of four antihypertensive agents on the Stroop colour-word test in normal male volunteer subjects.Psychopharmacology (Berl). 1977 Oct 20;54(2):133-8. doi: 10.1007/BF00426768. Psychopharmacology (Berl). 1977. PMID: 412207 Clinical Trial.
-
Effects of atenolol and propranolol on human performance and subjective feelings.Psychopharmacology (Berl). 1979 Jan 31;60(2):211-5. doi: 10.1007/BF00432296. Psychopharmacology (Berl). 1979. PMID: 106432 Clinical Trial.
-
Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.Drugs. 1986 Apr;31(4):301-36. doi: 10.2165/00003495-198631040-00003. Drugs. 1986. PMID: 3519177 Review.
-
Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.Br J Clin Pharmacol. 1988 Aug;26(2):121-8. doi: 10.1111/j.1365-2125.1988.tb03378.x. Br J Clin Pharmacol. 1988. PMID: 2905148 Free PMC article. Clinical Trial.
-
Time course of blood pressure, pulse rate, plasma renin and metoprolol during treatment of hypertensive patients.Eur J Clin Pharmacol. 1980 May;17(5):321-8. doi: 10.1007/BF00558443. Eur J Clin Pharmacol. 1980. PMID: 6998708
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources